Skip to content

Prehospital Resuscitation On Helicopter Study

Prehospital Resuscitation On Helicopter Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02272465
Acronym
PROHS
Enrollment
1049
Registered
2014-10-23
Start date
2015-01-31
Completion date
2015-12-31
Last updated
2015-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Injuries

Keywords

pre-hospital resuscitation, helicopter, trauma

Brief summary

The Prehospital Resuscitation On Helicopter Study (PROHS) is a pragmatic, multicenter, prospective observational study of air ambulance-based prehospital resuscitation regimens currently utilized at the participating sites. Patients will be enrolled at participating sites that currently have blood products available on air ambulances and other sites that do not. This study will not change the current prehospital standard of care for resuscitation. The primary outcome will be in-hospital mortality and the primary unit of analysis will be the patient. Other outcomes of interest will include time to hemostasis, hospital length-of-stay, number of ventilator-free and ICU-free days, incidence of major surgical procedures, complications (transfusion-related acute lung injury \[TRALI\], acute kidney injury \[AKI\], multiple organ failure \[MOF\], acute respiratory distress syndrome \[ARDS\], sepsis, intra-abdominal complications, thromboembolic complications, compartment syndromes), lifesaving interventions, the amount and type of blood products and concentrates transfused (including prehospital), wastage of prehospital blood products and concentrates, use of external and internal hemostatic devices, and functional status at discharge/discharge destination.

Detailed description

All patients arriving to the participating center's trauma emergency department via helicopter directly from the scene will be screened and initial data collected. Of that group, all patients who meet the highest risk category (based on vital signs, type of injury, use of tourniquet, and/or intubation) or received blood during transport will be followed through direct observation through the initial resuscitation period and then indirectly through medical chart review until hospital discharge or 30 days after admission (whichever occurs first).

Interventions

OTHERNo intervention

Observational study

Sponsors

University of Cincinnati
CollaboratorOTHER
Mayo Clinic
CollaboratorOTHER
Oregon Health and Science University
CollaboratorOTHER
University of Washington
CollaboratorOTHER
University of Maryland
CollaboratorOTHER
University of Alabama at Birmingham
CollaboratorOTHER
University of Arizona
CollaboratorOTHER
University of Southern California
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Resuscitation Outcomes Consortium
CollaboratorNETWORK
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Criteria for at risk population * Patients with traumatic injuries received directly from the scene via air ambulance service (did not receive a lifesaving intervention at an outside hospital or healthcare facility) * Estimated age of 15 or older or greater than/equal to a weight of 50 kg, if age unknown Criteria for highest risk population * Meet at least one of the following during prehospital care: HR \>120 bpm, SBP ≤90 mmHg, penetrating truncal injury, tourniquet application, pelvic binder application or intubation. * Received blood products during transport (for those facilities with blood product availability)

Exclusion criteria

* Prisoners (defined as those received directly from a correctional facility.

Design outcomes

Primary

MeasureTime frame
In-patient mortality.Up to 30 days

Other

MeasureTime frameDescription
Number of ICU daysUp to 30 days
Number of Ventilator daysUp to 30 days
Blood product usageUp to 30 daysNumber of RBCs, plasma and platelets used during resuscitation.
Length of hospital stayUp to 30 daysThe total # of hospital days
Number of patients with complicationsUp to 30 daysWill evaluate the number of patients who experienced common complication following traumatic injury.
Number of patients who required hemostatic devicesup to 30 daysThe use of external and internal hemostatic devices.
GOSE scoreUp to 30 daysGOSE score to measure functional status at time of discharge

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026